
Vitamin K antagonist plus clopidogrel feasible for PCI
(HealthDay)—Vitamin K antagonists (VKA) combined with clopidogrel may be a better alternative to triple anticoagulant therapy in patients on long-term VKA undergoing percutaneous coronary intervention (PCI) and stenting, ...
Sep 19, 2014
0
0